FT Options’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$147K Buy
+100,000
New +$7.65M 0.22% 81
2017
Q1
Sell
-134,000
Closed -$211K 318
2016
Q4
$211K Sell
134,000
-30,000
-18% -$2.23M 0.24% 74
2016
Q3
$270K Buy
164,000
+9,800
+6% +$796K 0.21% 88
2016
Q2
$387K Sell
154,200
-119,800
-44% -$10.6M 0.33% 59
2016
Q1
$507K Sell
274,000
-29,000
-10% -$2.62M 0.53% 40
2015
Q4
$840K Buy
+303,000
New +$31.5M 0.62% 45

Other funds holding GILD

FT Options's GILD Position: Q3 2017 in Review

FT Options opened a new position in Gilead Sciences (GILD) in Q3 2017: 11,581 shares worth $938K. The stake represents 1.41% of the portfolio and ranks #24 among its holdings. This is a return to the name: FT Options previously reported a position in GILD as recently as Q4 2016.

FT Options first reported a position in GILD in Q4 2015 and has held it in 6 quarters since. The position peaked at $12.7M in Q4 2015. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • FT Options held 11,581 shares of Gilead Sciences worth $938K as of Q3 2017.
  • Gilead Sciences was a new FT Options position in Q3 2017.
  • Gilead Sciences made up 1.41% of FT Options's portfolio in Q3 2017, its #24 holding.
  • FT Options first reported a position in Gilead Sciences in Q4 2015 and has held it in 6 quarters since.
  • FT Options's Gilead Sciences position peaked at $12.7M in Q4 2015.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.